Belgium· BE-AMP-SAM468471-00
Lymphoseek 50 µg
A technetium (99mtc) tilmanocept product containing tilmanocept, registered in Belgium by Navidea Biopharmaceuticals Europe. The same ATC class is registered in 3 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Technetium (99mtc) tilmanocept is registered in 3 of 19 countries.
Countries holding a registration under ATC V09IA09 (technetium (99mtc) tilmanocept), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 3 of them publish a price we can compare per daily dose
Technetium (99mtc) tilmanocept · ATC V09IA09
3 / 19 countries
- Belgiumprice
- Finlandprice
- Norwayprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Tilmanocept
- Manufacturer
- Navidea Biopharmaceuticals Europe
- Country
- Belgium (BE)
- ATC code
- V09IA09
- ATC class
- Technetium (99mTc) tilmanocept
- Defined daily dose
- 50 mcg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb3691029
- be_apb3691011
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Technetium (99mtc) tilmanocept in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainLYMPHOSEEK 50 MICROGRAMOS EQUIPO DE REACTIVOS PARA PREPARACION RADIOFARMACEUTICANavidea Biopharmaceuticals Europe Limited
- United KingdomLymphoseek 50microgram kit for radiopharmaceutical preparationNorgine Pharmaceuticals Ltd
- FinlandLymphoseekNavidea Biopharmaceuticals Europe Ltd.
- FranceLYMPHOSEEK 50 microgrammes, trousse pour préparation radiopharmaceutiqueNAVIDEA BIOPHARMACEUTICALS EUROPE (IRLANDE)
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9033c38f-e38f-433e-a737-5637d375247d GET /v1/drugs/9033c38f-e38f-433e-a737-5637d375247d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kit for radiopharmaceutical preparation",
"source": "afmps",
"status": "REVOKED",
"name_en": "Lymphoseek 50 µg",
"name_fr": "Lymphoseek 50 µg",
"name_nl": "Lymphoseek 50 µg",
"amp_code": "SAM468471-00",
"strengths": [
"250.0000",
"250.0000"
],
"pack_count": 2,
"substances": [
"Tilmanocept",
"Sodium Ascorbate",
"Sodium Hydroxide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Technetium (99mTc) Tilmanocept",
"authorisation_numbers": [
"EU/1/14/955/001",
"EU/1/14/955/002"
]
}See everything about technetium (99mtc) tilmanocept.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.